Cargando…
Saffron for the Management of Premenstrual Dysphoric Disorder: A Randomized Controlled Trial
BACKGROUND: Selective serotonin reuptake inhibitors are among the most common agents have been used for the treatment of the premenstrual dysphoric disorder (PMDD); however, due to the diversity in the outcomes and adverse effects, efforts are in progress to find an agent with maximal efficacy and m...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792881/ https://www.ncbi.nlm.nih.gov/pubmed/33457343 http://dx.doi.org/10.4103/abr.abr_49_20 |